Insider Trading & Ownership - Delfini Lisa

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Delfini Lisa
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-05-22
Sale
2024-05-24
4:12 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
4,350$2.6402$11,485101,404
(Direct)
View
2023-10-11
Sale
2023-10-12
4:00 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
785$2.02$1,586100,069
(Direct)
View
2023-09-11
Sale
2023-09-13
4:06 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
711$2.2$1,564100,854
(Direct)
View
2023-08-11
Sale
2023-08-14
4:00 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
682$2.36$1,610101,565
(Direct)
View
2023-07-11
Sale
2023-07-12
4:29 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
687$2.34$1,608102,247
(Direct)
View
2023-06-12
Sale
2023-06-14
4:28 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
610$2.64$1,610102,934
(Direct)
View
2023-05-11
Sale
2023-05-15
4:00 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
562$2.89$1,624103,544
(Direct)
View
2023-04-11
Sale
2023-04-12
5:02 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
840$1.839$1,545104,106
(Direct)
View
2023-03-13
Sale
2023-03-15
4:00 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
892$1.7532$1,564104,946
(Direct)
View
2023-02-13
Sale
2023-02-15
4:01 pm
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
8,474$2.45$20,761105,838
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-22
Exercise
2024-05-24
4:12 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
16,043$0101,404
(Direct)
View
2024-05-22
Exercise
2024-05-24
4:12 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
16,043$0.511101,404
(Direct)
View
2024-02-15
Option Award
2024-02-16
4:42 pm
N/A
2034-02-14
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
175,000$0175,000
(Direct)
View
2023-10-11
Exercise
2023-10-12
4:00 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0100,069
(Direct)
View
2023-10-11
Exercise
2023-10-12
4:00 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0.511100,069
(Direct)
View
2023-09-11
Exercise
2023-09-13
4:06 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0100,854
(Direct)
View
2023-09-11
Exercise
2023-09-13
4:06 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0.511100,854
(Direct)
View
2023-08-11
Exercise
2023-08-14
4:00 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0101,565
(Direct)
View
2023-08-11
Exercise
2023-08-14
4:00 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0.511101,565
(Direct)
View
2023-07-11
Exercise
2023-07-12
4:29 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0102,247
(Direct)
View
2023-07-11
Exercise
2023-07-12
4:29 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0.511102,247
(Direct)
View
2023-06-12
Exercise
2023-06-14
4:28 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0102,934
(Direct)
View
2023-06-12
Exercise
2023-06-14
4:28 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0.511102,934
(Direct)
View
2023-05-11
Exercise
2023-05-15
4:00 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0103,544
(Direct)
View
2023-05-11
Exercise
2023-05-15
4:00 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0.511103,544
(Direct)
View
2023-04-11
Exercise
2023-04-12
5:02 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0104,106
(Direct)
View
2023-04-11
Exercise
2023-04-12
5:02 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,292$0.511104,106
(Direct)
View
2023-03-13
Exercise
2023-03-15
4:00 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0104,946
(Direct)
View
2023-03-13
Exercise
2023-03-15
4:00 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
2,291$0.511104,946
(Direct)
View
2023-02-16
Option Award
2023-02-16
5:18 pm
N/A
2033-02-15
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
187,500$0187,500
(Direct)
View
2023-02-13
Exercise
2023-02-15
4:01 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
27,500$0105,838
(Direct)
View
2023-02-13
Exercise
2023-02-15
4:01 pm
N/A
N/A
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
27,500$0.511105,838
(Direct)
View
2022-02-11
Option Award
2022-02-15
4:00 pm
N/A
2032-02-10
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
110,000$0110,000
(Direct)
View
2021-08-09
Option Award
2021-08-09
5:34 pm
N/A
2031-08-08
Trevi Therapeutics Inc.TRVIDelfini Lisa
Chief Financial Officer
100,000$0100,000
(Direct)
View